OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.

Is Talon Therapeutics (OTCBB: TLON) Worth the Investment Even with an FDA Approval?

Posted on August 01, 2012 by OTC Equity

After hitting a high of 1.83 just two days ago shares of Talon Therapeutics (OTCBB: TLON) have come crashing down, sinking as low as 0.81 on Wednesday and the bleeding may just be getting started. While TLON is less than two weeks away from hearing the FDA's decision on Marqibo, their a novel, targeted Optisome(TM) encapsulated formulation product candidate for the treatment of Philadelphia negative Acute Lymphoblastic Leukemia (Ph-ALL) who have relapsed more than once and who are not responsive to further treatments, it appears as if investors have more concerns than just approval. Back in March TLON was given a shot in the arm when an FDA advisory committee recommended accelerated approval for Marqibo, seemingly paving the way for the biopharmaceutical company to get their first product on the market. Of course TLON played that vote up to investors and rightfully so but t...

To read the complete article sign up below; registration is free, you will only be asked to provide a valid email.

If you are not a registered user, registration is quick and easy - simply enter your email below and you are registered to view OTCEquity's Exclusive content. Your registration and membership is FREE, so register below now.